POCDOC

Smartphone-based platform for instant NCDs screening

Description

PocDoc is a platform technology enabling the full prevention funnel, from at-home screening and EHR integration to risk stratification and early treatment. Its multiplex flow assay in a disposable cartridge delivers multi-biomarker testing without expensive equipment, with results demonstrating alignment with NHS clinical standards. Launching first with cardiovascular, expanding into metabolic and renal panels.

Product

No items found.

Our Investment Thesis

  • Proprietary End-to-End Platform: PocDoc is not just delivering a test, but an integrated pathway. By owning the full stack; test result, algorithm, EHR integration, and onward routing - it improves accessibility, supports action after diagnosis, and embeds into healthcare workflows. As adoption grows, the platform captures richer data across the care journey, strengthening its model and competitive moat.
  • Large and expanding market: NCDs represent the dominant global disease burden across both developed and emerging markets. Low cost and equipment-free design removes traditional barriers to testing, while dual revenue channels across healthcare systems and health retail enable broad deployment globally.
  • Validated health impact: NHS co-authored health economic analysis suggests potential for billion-pound system savings; pilots confirm results align with National Cholesterol Education Program guidelines, influencing clinical decisions including lipid-lowering therapy initiation.

CEO

Steve Roest

Location

Cambridge, UK

Website

Visit Site

Theme

#PreventiveCare
#SelfCare